KK
PACB icon

KLP Kapitalforvaltning’s Pacific Biosciences PACB Stock Holding History

KLP Kapitalforvaltning’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,800
Closed -$48.1K – 2248
2025
Q1 		$48.1K Hold
40,800
– – ﹤0.01% 2198
2024
Q4 		$74.7K Buy
+40,800
New +$79.6K ﹤0.01% 2174

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KLP Kapitalforvaltning's PACB Position: Q2 2025 in Review

KLP Kapitalforvaltning sold out of Pacific Biosciences (PACB) in Q2 2025, closing a stake of 40,800 shares — an estimated $48.1K sold.

KLP Kapitalforvaltning first reported a position in PACB in Q4 2024 and held it in 2 quarters. The position peaked at $74.7K in Q4 2024. 207 funds tracked by Wall St. Rank hold PACB as of Q2 2025.

  • KLP Kapitalforvaltning reported no remaining Pacific Biosciences position as of Q2 2025 after selling out during the quarter.
  • KLP Kapitalforvaltning sold 40,800 Pacific Biosciences shares in Q2 2025, an estimated $48.1K.
  • KLP Kapitalforvaltning first reported a position in Pacific Biosciences in Q4 2024 and held it in 2 quarters.
  • KLP Kapitalforvaltning's Pacific Biosciences position peaked at $74.7K in Q4 2024.
  • 207 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2025.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2025, filed 23 Jul 2025.